Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
- Defining the Molecular Point of Care (mPOC) Market in 2024 March 14, 2024
- Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment March 8, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
New Study Predicts 1,000+ Urgent Care Centers Opening in the US Over Next Five Years
A New study from Kalorama Information said that the number of urgent care centers in the US is expected to increase from approximately 10,600 currently to more than 12,000 by 2023. The report, The Market for U.S. Urgent Care projects a growing market for the urgent care center business and a growing market for suppliers […]
AACC 2019 Anaheim: A Demand for Faster, Better, and More Relevant Tests
Kalorama Information attended the American Association of Clinical Chemistry in Anaheim this year. We analyzed products and trends, interviewed vendors and experts, and gathered information for our 12 Edition Worldwide Market for In Vitro Diagnostics Tests report, due out this month. Time is of the essence, it is said, and that was the case […]
Our Latest Report on Next-Generation Sequencing Finds Brisk Vendor Sales, but also Users With Unaddressed Needs
The DNA sequencer market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. It is a 4 billion […]
Introducing: The Kalorama Clinical Masterfile
Announcing a new product from Kalorama Information, Part of the Science and Medicine Group. The Kalorama Clinical Masterfile. For the best business results, clinical diagnostics marketers need knowledge about several elements: What products do my customers currently have? What types of products? Clinical Chemistry, Micro, Molecular, Immunoassays, Hematology? How old are those systems? Is it […]
The World Market for Biomarkers
We have just published our latest report, The World Market for Biomarkers. Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, […]
Understanding the Clinical Diagnostics Customer Experience
We recently published a customer experience survey. This blog highlights discusses the report and highlights the major findings of the report, including important recommendations for the clinical diagnostics industry. For specific vendor performance and user ratings, a purchase of the report is suggested. Clinical laboratory customers have become increasingly sophisticated and typically have multiple suppliers […]
Milestone Reached for Kalorama Information under New Ownership as Part of Science and Medicine Group
Kalorama Information, a part of Science and Medicine Group, has announced that it has published its 25th report since the acquisition of the company by Science and Medicine Group. Since November, the firm has reported on food safety testing, infectious disease, Latin American Markets, molecular diagnostics and many other markets. “Experts in sequencing, liquid biopsy, […]
Red Flags Raised With CLIA Waived Test Growth
As reported on LabPulse.com (Sign up at http:www.labpulse.com) — Providers of proficiency testing for CLIA tests are becoming increasingly concerned about the lack of external quality control and oversight of CLIA-waived test kits, as the number of waived kits continues to expand. Some 1,400 waived test kits are now on the market, compared with 30 […]
Quidel and Abbott Lead in POC Cardiac Markers
Quidel is the market leader in point-of-care (POC) cardiac markers, according to a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among the top companies. The findings were reported in Kalorama Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics. Quidel is a market leader in rapid immunoassays and […]
IVDs Essential as U.S. Measles Cases Reach 27-Year High
There has been a milestone reached in 2019, but not one to celebrate. There are now more cases of measles in the United States than any time since 1992. 1,077 individual measles cases were confirmed as of June 2019, according to the Centers for Disease Control and Prevention (CDC). With doctors less familiar than they […]